Drugs Made In America Acquisition Corp
Key Figures
-- Open
0.000 High
4.00 Volume
-- P/E TTM
-- P/E Dynamic
-- Dividend TTM
-- Turnover Ratio
10.610 Prev. Close
0.000 Low
50.00 Turnover
-- P/E Static
-- P/B
0.00% Div Yield TTM
-- ROA
10.604 52wk High
0.00 Volume Ratio
-- Net Profit
-- Shares
-- EPS TTM
-- Beta
-- ROE
10.000 52wk Low
0.00% Amplitude
-- Gross Margin
0.00 Market Cap
-1.95 Reward/Risk
0.95% Risk Rate
TradingKey Stock Score No stock score available due to insufficient data.
Drugs Made In America Acquisition Corp News
View more
More news coming soon, stay tuned...
Financial Indicators EPS Relevant data have not been disclosed by the company yet.
Total revenue Relevant data have not been disclosed by the company yet.
Drugs Made In America Acquisition Corp Info Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Ticker Symbol DMAAU
Company Drugs Made In America Acquisition Corp
CEO Stockwell (Lynn)
Website
FAQs
What is the current price of Drugs Made In America Acquisition Corp (DMAAU)? The current price of Drugs Made In America Acquisition Corp (DMAAU) is 10.80.
What is the symbol of Drugs Made In America Acquisition Corp? The ticker symbol of Drugs Made In America Acquisition Corp is DMAAU.
What is the 52-week high of Drugs Made In America Acquisition Corp? The 52-week high of Drugs Made In America Acquisition Corp is 10.60.
What is the 52-week low of Drugs Made In America Acquisition Corp? The 52-week low of Drugs Made In America Acquisition Corp is 10.00.
What is the market capitalization of Drugs Made In America Acquisition Corp? The market capitalization of Drugs Made In America Acquisition Corp is 258.55M.